Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A potent
inhibitor ofVEGF receptor tyrosine kinases , under development as a possibleanticancer drug .
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word cediranib.
Examples
-
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients ...
THE MEDICAL NEWS Editors 2010
-
Since this past November, I've been taking a fairly hefty dose of cediranib, a relatively new experimental anti-cancer drug.
Penmachine 2009
-
"This outcome is encouraging and provides evidence that cediranib should be further studied in future clinical trials in young patients with these and other sarcomas to determine the activity of this new agent," Fox said.
THE MEDICAL NEWS 2009
-
The researchers are currently evaluating the effects with 17 mg/m2 of cediranib and proposed to the Children's Oncology Group that a phase II study be conducted in selected childhood solid tumors.
THE MEDICAL NEWS 2009
-
"There are a number of antiangiogenic agents, like cediranib, in development for adult cancers," said researcher Elizabeth Fox, M.D.,
THE MEDICAL NEWS 2009
-
Journal of Clinical Oncology, received funding from AstraZeneca Pharmaceuticals, which manufactures cediranib under the brand name Recentin.
-
In this study, a Massachusetts General Hospital team found that the experimental anti-angiogenesis drug cediranib reduced edema and improved survival in mice with glioblastomas.
-
The investigational drug AZD2171 (cediranib) may help shrink tumors and prolong survival of patients ...
THE MEDICAL NEWS 2009
-
Previous research showed that cediranib temporarily normalized abnormal, leaky blood vessels that had recurred after surgery, radiation or chemotherapy for glioblastoma, reducing edema and the size of tumors.
-
Leading researchers will present new and exciting data on the role of hsp70 as a novel therapy for breast cancer; various drug compounds that kill leukemia stem cells and yet spare normal stem cells; tolerability results of cediranib for use in children with recurrent or refractory solid tumors; and sensitivity study results of olaparib for colorectal cancer cells containing a specific DNA repair defect.
THE MEDICAL NEWS 2009
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.